SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Pastimes : My House -- Ignore unavailable to you. Want to Upgrade?


To: Original Mad Dog who wrote (5509)2/27/2003 5:52:18 PM
From: Lost1  Read Replies (1) | Respond to of 7689
 
I think they care less about facts, right or wrong, and feel no moral obligation other than to their own financial "needs"/wants



To: Original Mad Dog who wrote (5509)2/27/2003 7:20:38 PM
From: Lazarus_Long  Respond to of 7689
 
Message 18633912
siliconinvestor.com



To: Original Mad Dog who wrote (5509)2/28/2003 10:18:06 AM
From: thames_sider  Respond to of 7689
 
and even more mad dog stuff...

uk.news.yahoo.com

I think it suspicious that the dogs are identified as German. How did they know...?



To: Original Mad Dog who wrote (5509)2/28/2003 7:20:38 PM
From: Lazarus_Long  Respond to of 7689
 
Had your slime today?

Superbug killer found in rockpool

Thursday, February 27, 2003 Posted: 5:35 AM EST (1035 GMT)

EDINBURGH, Scotland -- Scientists
may have found the answer to
Britain's most dangerous hospital
superbug -- in slime taken from
Scottish rock pools.

Several types of bacteria found by the
five-person team produce an antibiotic
that acts against the notorious hospital
superbug, MRSA (Methicillin Resistant
Staphylococcus Aureus.)

One in particular is so effective it is
already attracting keen interest from the
big drug companies.

Dr Jonathan David, technical director at
the scientists' company AquaPharm
Bio-Discovery Ltd, told the Press
Association: "It appears to be very potent
in terms of what concentration is required to kill MRSA.

"It completely stops them dead, preventing any further growth and killing the existing
bacteria."

MRSA, which has swept through hospitals in the UK over the past decade, is
impervious to most antibiotics and poses the greatest threat to patients who have
undergone surgery.

In 1991, it accounted for just under two percent of 4,966 reports of staphylococcus
blood infection in hospitals in England and Wales.

By 2001 that figure had risen to 41 percent of 12,631 reports.

AquaPharm is keeping the identity of its MRSA-killing bacteria a closely guarded
secret, and taken out patents on how they can be cultivated and used.

The bacteria produce a natural powerful antibiotic to fight off other bugs that might
want to invade their colony sites.

They are collected by scraping off the surface slime from rocks, plants and
invertebrates such as sea anemones.

"It's essentially beachcombing," said Dr David.

"We go for whatever we think is likely to be of interest. There are certain sites to look
for -- basically it's down to experience.

"Usually we take some of the substrate on which the bacteria live and put it in vials."
cnn.com